Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibopamine 2% eye drops for ocular hypotony after vitreoretinal surgery or uveitis
NL-OMON21285Active, not recruiting
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Ibopamine in Ocular hypotension. Primary endpoints: Ocular pressure and Vision. Started Mar 2004; status: active, not recruiting.
02
Drugs
Ibopamine
03
Conditions
Ocular hypotension
Beyond the preview
Go deeper on NL-OMON21285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21285.